Sodium 18F-Fluoride Bone Scintigraphy in Deep Ocean Diver

被引：1
|
作者：
Lim, Jin T. E. [1 ]
Moncayo, Valeria M. [1 ]
Alazraki, Naomi [1 ,2 ]
机构：
[1] Emory Univ, Dept Radiol & Imaging Sci, Div Nucl Med & Mol Imaging, Atlanta, GA 30322 USA
[2] Vet Affairs Med Ctr, Nucl Med Serv, Atlanta, GA 30033 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2015年 / 40卷 / 07期
关键词：
METASTASES; INFARCT;
D O I：
10.1097/RLU.0000000000000801
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Sodium F-18-fluoride (NaF) is a diagnostic marker for new bone formation in bone scintigraphy that was approved by US FDA in 1972 but discontinued in 1984. We report a case of a US naval officer who spent time living and working in an oceanic lab, 205 feet below the surface. Plain skeletal films of femurs 4 years later demonstrate bilateral bone infarcts. Corresponding sodium F-18-fluoride bone scintigraphy demonstrates low-normal to decreased tracer activity. This rectilinear scan image is of historical interest. Other bone scintigraphic radiotracers used in the past and present will be briefly discussed.
引用
收藏
页码：582 / 584
页数：3
相关论文
共 39 条
  • [1] Sodium 18F-Fluoride PET/CT of Bone, Joint, and Other Disorders
    Jadvar, Hossein
    Desai, Bhushan
    Conti, Peter S.
    SEMINARS IN NUCLEAR MEDICINE, 2015, 45 (01) : 58 - 65
  • [2] SNM Practice Guideline for Sodium 18F-Fluoride PET/CT Bone Scans 1.0
    Segall, George
    Delbeke, Dominique
    Stabin, Michael G.
    Even-Sapir, Einat
    Fair, Joanna
    Sajdak, Rebecca
    Smith, Gary T.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (11) : 1813 - 1820
  • [3] Assessment of malignant skeletal disease:: Initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT
    Even-Sapir, E
    Metser, U
    Flusser, G
    Zuriel, L
    Kollender, Y
    Lerman, H
    Lievshitz, G
    Ron, I
    Mishani, E
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (02) : 272 - 278
  • [4] Bone scanning with sodium 18F-fluoride PET and PET/CT - German guideline Version 1.0
    Hellwig, D.
    Krause, B. -J.
    Schirrmeister, H.
    Freesmeyer, M.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2010, 49 (05): : 195 - 201
  • [5] 18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers
    Withofs, Nadia
    Grayet, Benjamin
    Tancredi, Tino
    Rorive, Andree
    Mella, Christine
    Giacomelli, Fabrice
    Mievis, Frederic
    Aerts, Joel
    Waltregny, David
    Jerusalem, Guy
    Hustinx, Roland
    NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (03) : 168 - 176
  • [6] Effect of Erythropoietin on Bone Marrow Uptake of 18F-Fluorocholine in Prostate Cancer Comparison With 18F-Fluoride Uptake
    Balogova, Sona
    Huchet, Virginie
    Egrot, Christoph
    Michaud, Laure
    Paycha, F.
    Kerrou, Khaldoun
    Montravers, Francoise
    Cussenot, Olivier
    Talbot, Jean Noel
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (03) : 200 - 202
  • [7] Quantification of 18F-Fluoride Kinetics: Evaluation of Simplified Methods
    Raijmakers, Pieter
    Temmerman, Olivier P. P.
    Saridin, Carrol P.
    Heyligers, Ide C.
    Becking, Alfred G.
    van Lingen, Arthur
    Lammertsma, Adriaan A.
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (07) : 1122 - 1127
  • [8] Current status of the use of 18F-sodium fluoride in bone disease
    de Arcocha, M.
    Portilla-Quattrociocchi, H.
    Medina-Quiroz, P.
    Carril, J. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2012, 31 (01): : 51 - 57
  • [9] SUV Normalized by Skeletal Volume on 18F-Fluoride PET/CT Studies
    Carvalho, Giovanna
    Gomes Marin, Jose Flavio
    Garcez, Alexandre Teles
    Duarte, Paulo Schiavom
    Sapienza, Marcelo Tatit
    Buchpiguel, Carlos Alberto
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (07) : 529 - 533
  • [10] Prevalence of Clinically Significant Extraosseous Findings on Unenhanced CT Portions of 18F-Fluoride PET/CT Bone Scans
    Chen, Chao-Jung
    Ma, Shih-Ya
    SCIENTIFIC WORLD JOURNAL, 2012,
1234